“Durable Efficacy of Certolizumab Pegol Dosed at 400 Mg Every Two Weeks Over 128 Weeks in Patients With Plaque Psoriasis Enrolled in Three Phase 3 Trials (CIMPASI-1, CIMPASI-2 and CIMPACT)”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s45. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/994.